Key Takeaways Accelerated adoption in epilepsy centers and new indications could rapidly expand NeuroPace's accessible market, driving sustained outperformance versus expectations. Proprietary EEG data and AI analytics are opening lucrative recurring revenue streams and supporting long-term margin improvement.Read more

Key Takeaways Persistent pricing pressure, data privacy concerns, and a limited addressable market threaten revenue growth and sustainable operating margins. Industry shifts toward non-invasive solutions and substantial investment needs may undermine sales volume, profitability, and long-term cash flow.Read more

Key Takeaways Expanding presence in epilepsy centers and Project CARE may significantly boost revenue by increasing market penetration and service delivery. AI-enhancements and clinical program advancements promise operational efficiency, new revenue streams, and improved financial performance.Read more
